Prenetics Global FY26 Sales Guidance of $220M-$230M Beats $214M Estimate
Prenetics Global forecasts FY26 sales between $220.000 million and $230.000 million, beating the $214.071 million analyst estimate. The guidance implies a minimum 2.8% upside to consensus, reflecting strong underlying business momentum.
*this image is generated using AI for illustrative purposes only.
Prenetics Global (NASDAQ: PRE) has provided full-year sales guidance for FY26, projecting revenue between $220.000 million and $230.000 million. The company’s outlook exceeds the consensus analyst estimate of $214.071 million, indicating a potential upside of approximately $5.9 million to $15.9 million over market expectations.
The guidance suggests that Prenetics Global anticipates robust performance across its business segments for the remainder of the fiscal year. By setting a floor of $220.000 million, the company is signaling confidence in its ability to outperform current market consensus by a margin of at least 2.8%.
What the Numbers Show
The divergence between the lower end of the guidance range and the analyst estimate highlights a notable shift in market sentiment versus management’s internal projections. While the analyst estimate sits at $214.071 million, the company’s conservative floor is $220.000 million. This gap implies that either recent operational developments have strengthened the company’s position beyond what analysts had priced in, or that previous estimates were based on more cautious assumptions regarding volume or pricing.
| Metric | Value |
|---|---|
| Analyst Estimate (FY26 Sales): | $214.071 million |
| Company Guidance Low (FY26 Sales): | $220.000 million |
| Company Guidance High (FY26 Sales): | $230.000 million |
No other financial metrics, such as net profit, EBITDA, or segment-wise breakdowns, were disclosed in the filing. Investors will need to await further disclosures for a complete picture of profitability and margin trends alongside this top-line guidance.
Which specific business segments or geographic regions are expected to drive the majority of the upside between the $220M floor and the $230M ceiling?
How might this revenue beat impact Prenetics Global's gross margins and EBITDA, given that profitability metrics were not disclosed?
What operational changes or strategic initiatives has management implemented that justify the higher confidence compared to previous analyst assumptions?
20
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
